Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular Pain|February 1, 2006
Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in ratsBenjamin Storek, Nina M Harder, Michaela S Banck, et al.
Cancer Research|June 3, 2004
Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1Sharon Benzeno, Goutham Narla, Jorge Allina, et al.
Pain Medicine (Malden, Mass.)|December 28, 2018
Unilateral Epidural Targeting of Resiniferatoxin Induces Bilateral Neurolysis of Spinal Nociceptive AfferentsMark D Unger, Josef Pleticha, Joanne Steinauer, et al.
Journal of the Neurological Sciences|February 5, 2020
Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genesJennifer G Le-Rademacher, Camden L Lopez, Rahul Kanwar, et al.
Journal of the Neurological Sciences|July 6, 2015
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)Ganesh K Boora, Amit A Kulkarni, Rahul Kanwar, et al.
Epigenetics|January 27, 2015
Plasticity of DNA methylation in a nerve injury model of painMeike Gölzenleuchter, Rahul Kanwar, Manal Zaibak, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2017
Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trialsJennifer Le-Rademacher, Rahul Kanwar, Drew Seisler, et al.
The Journal of Clinical Investigation|May 17, 2013
The genomic landscape of small intestine neuroendocrine tumorsMichaela S Banck, Rahul Kanwar, Amit A Kulkarni, et al.
Annals of Neurology|August 29, 2014
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathyAndreas S Beutler, Amit A Kulkarni, Rahul Kanwar, et al.
Oncotarget|April 21, 2017
Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to deliveryAlan H Bryce, Jan B Egan, Mitesh J Borad, et al.
Pageof 3